Estimating Usual Iodine Intake From Spot Urinary Iodine Concentrations (ITURN)

May 26, 2022 updated by: Maria Andersson, Swiss Federal Institute of Technology

Estimating the Usual Iodine Intake From Spot Urinary Iodine Concentrations to Obtain the Prevalence of Inadequate or Excess Iodine Intake in School-aged Children and Adults

The overall objective of this study is to develop a reliable method to obtain habitual iodine intakes from spot urinary iodine concentration (UIC) and to assess the prevalence of inadequate iodine intake in school-age children and women of reproductive age. We will evaluate different methods to estimate iodine intake from UIC and estimate the prevalence of inadequate and excess iodine intake in UIC studies conducted in populations with low, adequate and high iodine intakes using the the established estimated average requirement (EAR)/Tolerable Upper Intake Level (UL) cut-point method.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

1592

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Morobe
      • Sia, Morobe, Papua New Guinea
        • University of Papua New Guinea
      • Saint Petersburg, Russian Federation
        • Almazov Medical Research Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

9 years to 13 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Apparently healthy school-age children and women of reproductive age

Description

Inclusion Criteria:

  • lived in study area >= 12 months
  • no reported intake of Amiodarone
  • no history of thyroid dysfunction / goiter (past & present)
  • no exposure to iodine containing contrast agents within the last 12 months

Second arm: Women aged 18 - 49, exclusion / inclusion criteria apply, plus non-pregnant, non-lactating.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Ecologic or Community
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
St. Petersburg: School aged children
Generally healthy 9 to 12 years old children
St. Petersburg: Women of reproductive age
Generally healthy non-pregnant, non-lactating women between 18 and 44 years of age
Papua New Guinea: School aged children
Generally healthy 9 to 12 years old children

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Estimated iodine intake
Time Frame: 17 months
Estimated daily iodine intake of the study population derived from urinary iodine and creatinine concentrations measured in spot urine samples
17 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Urinary iodine concentration
Time Frame: 17 months
Measured in spot urine samples and 24 h urine collections
17 months
Urinary creatinine concentration
Time Frame: 17 months
Measured in spot urine samples and 24 h urine collections
17 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2018

Primary Completion (Actual)

February 21, 2020

Study Completion (Actual)

February 21, 2020

Study Registration Dates

First Submitted

July 18, 2018

First Submitted That Met QC Criteria

July 18, 2018

First Posted (Actual)

July 26, 2018

Study Record Updates

Last Update Posted (Actual)

June 1, 2022

Last Update Submitted That Met QC Criteria

May 26, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • ITURN

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Iodine Deficiency

Subscribe